Pinakhina Daria, Kasyanov Evgeny, Rukavishnikov Grigory, Larin Andrey K, Veselovsky Vladimir A, Rakitko Alexander, Neznanov Nikholay, Kibitov Alexander, Mazo Galina, Artomov Mykyta
V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint-Petersburg, Russia.
Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia.
Front Psychiatry. 2024 Dec 5;15:1416009. doi: 10.3389/fpsyt.2024.1416009. eCollection 2024.
An association between the () intron variant rs521851 and depression symptoms, as measured by the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), has been recently reported. The role of in depression has been linked to disruptions in the gut-brain axis. In this study, we investigated the association between rs521851 and HADS-D scores in an independent cohort of 380 individuals, consisting of 238 patients with an ICD-10 diagnosis of depression and 142 healthy controls. The original association was replicated in the patient cohort but not in the control group. Further analysis revealed that the effect size of rs521851 on HADS-D scores was moderated by Eating Attitudes Test 26 (EAT-26) scores. In participants with an EAT-26 score of ≥20, the effect size of rs521851 on HADS-D was more than 20 times greater compared to those with an EAT-26 score of <20. These findings successfully replicate the original association signal for and HADS-D, and highlight the role of in gut-brain interactions.
最近有报告称,通过医院焦虑抑郁量表(HADS-D)的抑郁分量表测量,()内含子变体rs521851与抑郁症状之间存在关联。其在抑郁症中的作用与肠-脑轴的紊乱有关。在本研究中,我们在一个由380名个体组成的独立队列中调查了rs521851与HADS-D评分之间的关联,该队列包括238名国际疾病分类第十版(ICD-10)诊断为抑郁症的患者和142名健康对照。最初的关联在患者队列中得到了重复,但在对照组中未得到重复。进一步分析表明,rs521851对HADS-D评分的效应大小受饮食态度测试26(EAT-26)评分的调节。在EAT-26评分≥20的参与者中,rs521851对HADS-D的效应大小比EAT-26评分<20的参与者大20倍以上。这些发现成功地重复了最初关于其与HADS-D的关联信号,并突出了其在肠-脑相互作用中的作用。